IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $978,508 | +56.5% | 21,572 | +41.5% | 0.00% | 0.0% |
Q2 2023 | $625,420 | +28.4% | 15,243 | +11.8% | 0.00% | 0.0% |
Q1 2023 | $487,208 | -3.9% | 13,632 | +1.5% | 0.00% | 0.0% |
Q4 2022 | $507,176 | -17.4% | 13,428 | -3.3% | 0.00% | 0.0% |
Q3 2022 | $614,000 | +30.4% | 13,892 | +9.1% | 0.00% | 0.0% |
Q2 2022 | $471,000 | -0.2% | 12,729 | -0.2% | 0.00% | 0.0% |
Q1 2022 | $472,000 | +2.6% | 12,758 | -15.6% | 0.00% | 0.0% |
Q4 2021 | $460,000 | -8.0% | 15,116 | +1.3% | 0.00% | 0.0% |
Q3 2021 | $500,000 | -5.8% | 14,915 | +12.0% | 0.00% | 0.0% |
Q2 2021 | $531,000 | -73.3% | 13,320 | -69.8% | 0.00% | -75.0% |
Q1 2021 | $1,986,000 | -0.9% | 44,179 | +24.7% | 0.00% | 0.0% |
Q4 2020 | $2,004,000 | +19.0% | 35,440 | -0.1% | 0.00% | 0.0% |
Q3 2020 | $1,684,000 | +48.1% | 35,487 | +84.0% | 0.00% | +33.3% |
Q2 2020 | $1,137,000 | +24.9% | 19,286 | +0.2% | 0.00% | 0.0% |
Q1 2020 | $910,000 | -28.5% | 19,246 | -8.6% | 0.00% | -25.0% |
Q4 2019 | $1,272,000 | -8.8% | 21,051 | -9.6% | 0.00% | -20.0% |
Q3 2019 | $1,395,000 | -4.9% | 23,285 | -1.9% | 0.01% | 0.0% |
Q2 2019 | $1,467,000 | -20.1% | 23,733 | +4.9% | 0.01% | -28.6% |
Q1 2019 | $1,837,000 | +23.9% | 22,627 | -17.5% | 0.01% | +16.7% |
Q4 2018 | $1,483,000 | +8.0% | 27,435 | +3.1% | 0.01% | +20.0% |
Q3 2018 | $1,373,000 | +35.7% | 26,618 | +9.5% | 0.01% | +25.0% |
Q2 2018 | $1,012,000 | -3.1% | 24,298 | +2.6% | 0.00% | 0.0% |
Q1 2018 | $1,044,000 | -18.2% | 23,687 | -6.6% | 0.00% | -20.0% |
Q4 2017 | $1,276,000 | -1.3% | 25,366 | -0.5% | 0.01% | -16.7% |
Q3 2017 | $1,293,000 | -4.1% | 25,503 | -3.8% | 0.01% | -14.3% |
Q2 2017 | $1,348,000 | +24.8% | 26,499 | -1.3% | 0.01% | +16.7% |
Q1 2017 | $1,080,000 | -11.2% | 26,856 | +5.7% | 0.01% | -14.3% |
Q4 2016 | $1,216,000 | +26.5% | 25,414 | -3.1% | 0.01% | +16.7% |
Q3 2016 | $961,000 | +56.0% | 26,215 | -1.0% | 0.01% | +50.0% |
Q2 2016 | $616,000 | -25.7% | 26,467 | +29.3% | 0.00% | -33.3% |
Q1 2016 | $829,000 | -42.1% | 20,476 | -13.6% | 0.01% | -50.0% |
Q4 2015 | $1,432,000 | – | 23,693 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,463,400 | $418,566,000 | 6.01% |
Tweedy, Browne Co LLC | 2,722,988 | $120,438,000 | 5.30% |
BVF INC/IL | 2,872,953 | $127,071,000 | 5.25% |
Sicart Associates LLC | 253,976 | $11,233,000 | 3.98% |
Parkman Healthcare Partners LLC | 241,945 | $10,701,000 | 3.04% |
Camber Capital Management LP | 1,925,000 | $85,143,000 | 2.61% |
Privium Fund Management B.V. | 148,807 | $6,589,000 | 2.39% |
SECTOR GAMMA AS | 164,223 | $7,264,000 | 1.87% |
HANSEATIC MANAGEMENT SERVICES INC | 10,993 | $486,000 | 1.31% |
BRANDYWINE MANAGERS, LLC | 8,460 | $374,000 | 1.23% |